justaevolvedchimp1784458866

The science worked. GLP-1 drugs changed how we treat obesity overnight. But a medical breakthrough instantly became a digital gold rush. Look past the clinical headlines and you find the secondary market. Compounded versions. Online pushers. A JAMA Health Forum study found that websites selling compounded GLP-1s routinely feed potential patients partial facts or outright misinformation. Another study shows a massive chunk of patients quit the therapy within twelve months. We built a powerful tool for a complex health crisis. But we let the delivery system become a loud, uneven marketplace where the quality of your care depends entirely on who takes your credit card.